The Spark
Medicon Village ScheelevAegen 1
Lund 223 81
Sweden
46 7 03 05 24 88
https://diagonalbio.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 4
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Ms. Karin Wehlin MBA | Chief Executive Officer | 64k | N/A | 1963 |
Mr. Kushagr Punyani | Tech Advisor, Founding Partner & Director | 100k | N/A | 1991 |
Mr. Andreas Nyberg | Founder & Chief Scientific Officer | N/A | N/A | N/A |
Mr. Johan Kallstrand | Founding Partner | N/A | N/A | N/A |
Ms. Fata Mrsic | Chief Financial Officer | N/A | N/A | N/A |
Diagonal Bio AB (publ) operates as a biotechnology company in Sweden. The company offers LAMPlify, a customized system for general laboratory use to identify the presence of specific genetic markers for, for example, fungi, viruses, or bacteria. It is also involved in the development of PANVIRAL, a universal in vitro diagnostic system, that offers the potential for rapid and accurate point-of-care diagnoses in various settings, such as doctor's office, surgery, mobile clinics, hospital bedsides, and workplaces and airports. The company was incorporated in 2020 and is based in Lund, Sweden.
Diagonal Bio AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.